Late presentation (LP) for HIV care across Europe remains a significant issue. We provide a cross-European update from 34 countries on the prevalence and risk factors of LP for 2010–2013. People aged ≥ 16 presenting for HIV care (earliest of HIV-diagnosis, first clinic visit or cohort enrolment) after 1 January 2010 with available CD4 count within six months of presentation were included. LP was defined as presentation with a CD4 count
Members of the Ecdc HIv/Aids Surveillance And Dublin Declaration Monitoring Network: Portugal: Isabe...
Background: Early diagnosis of HIV infection can prevent morbidity and mortality as well as reduce H...
textabstractObjectives: Early testing for HIV and entry into care are crucial to optimise treatment ...
Late presentation (LP) for HIV care across Europe remains a significant issue. We provide a cross-Eu...
Background:Few studies have monitored late presentation (LP) of HIV infection over the European cont...
Few studies have monitored late presentation (LP) of HIV infection over the European continent, incl...
In 2014, there were 36.9 million people worldwide living with human immunodeficiency virus (PLWH), o...
With the purpose of reducing the well-known negative impact of late presentation (LP) on people livi...
OBJECTIVES: Across Europe, almost a third of individuals infected with HIV do not enter health care ...
Objectives: In Europe, 15-38% of individuals with HIV infection are diagnosed late in the course of ...
With universal access to antiretroviral therapy (ART), people can access effective treatment but are...
Background: The aim of our study was to assess the extent of late presentation for HIV care in North...
Introduction: Late HIV diagnosis is common and associated with an increased risk of clinical progres...
Objective The central goal of the HIV in Europe Initiative is to promote testing and treatment throu...
To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set ...
Members of the Ecdc HIv/Aids Surveillance And Dublin Declaration Monitoring Network: Portugal: Isabe...
Background: Early diagnosis of HIV infection can prevent morbidity and mortality as well as reduce H...
textabstractObjectives: Early testing for HIV and entry into care are crucial to optimise treatment ...
Late presentation (LP) for HIV care across Europe remains a significant issue. We provide a cross-Eu...
Background:Few studies have monitored late presentation (LP) of HIV infection over the European cont...
Few studies have monitored late presentation (LP) of HIV infection over the European continent, incl...
In 2014, there were 36.9 million people worldwide living with human immunodeficiency virus (PLWH), o...
With the purpose of reducing the well-known negative impact of late presentation (LP) on people livi...
OBJECTIVES: Across Europe, almost a third of individuals infected with HIV do not enter health care ...
Objectives: In Europe, 15-38% of individuals with HIV infection are diagnosed late in the course of ...
With universal access to antiretroviral therapy (ART), people can access effective treatment but are...
Background: The aim of our study was to assess the extent of late presentation for HIV care in North...
Introduction: Late HIV diagnosis is common and associated with an increased risk of clinical progres...
Objective The central goal of the HIV in Europe Initiative is to promote testing and treatment throu...
To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set ...
Members of the Ecdc HIv/Aids Surveillance And Dublin Declaration Monitoring Network: Portugal: Isabe...
Background: Early diagnosis of HIV infection can prevent morbidity and mortality as well as reduce H...
textabstractObjectives: Early testing for HIV and entry into care are crucial to optimise treatment ...